Warrant Amendment Agreement between Heart Test Laboratories, Inc. and Matthews Southwest Holdings, Inc. (November 16, 2023)
Heart Test Laboratories, Inc. and Matthews Southwest Holdings, Inc. have agreed to amend certain warrants to purchase common stock, in connection with a debt conversion. The amendment reduces the exercise price of the specified warrants to $0.16 per share. All other terms of the original warrants remain unchanged. The company will provide amended warrants reflecting this change in exchange for the old ones, upon request. This agreement is effective as of the closing of the debt conversion.
Exhibit 10.3
November 16, 2023
Holder of Warrants to Purchase Common Stock set forth on Exhibit A attached hereto
Re: Amendment to Existing Warrants
Dear Holder:
Reference is hereby made to the conversion of the promissory note into equity on the date hereof (the “Debt Conversion”) by Heart Test Laboratories, Inc., (the “Company”) and Matthews Holdings Southwest, Inc. (“Holder”).
This letter confirms that, in contemporaneous with the Debt Conversion, the Company hereby amends, effective as of the closing of the Debt Conversion and upon the satisfaction of the other terms and conditions referenced below, the warrants to purchase Common Stock, par value $0.001 per share, of the Company set forth on Exhibit A hereto (the “Existing Warrants”) by reducing the Exercise Price (as defined therein) of the Existing Warrants to $0.16 per share (the “Warrant Amendment”).
Except as expressly set forth herein, the terms and provisions of the Existing Warrants shall remain in full force and effect after the execution of this letter and shall not be in any way changed, modified or superseded except by the terms set forth herein.
From and after the effectiveness of the Warrant Amendment, the Company agrees to promptly deliver to the Holder, upon request, amended Existing Warrants that reflect the Warrant Amendments in exchange for the surrender for cancellation of the Holder’s Existing Warrants to be amended as provided herein.
[Signature Page Follows]
IN WITNESS WHEREOF, the parties hereto have caused this agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
HEART TEST LABORATORIES, INC. | ||
By: | /s/ Andrew Simpson | |
Name: | Andrew Simpson | |
Title: | Chief Executive Officer |
Name of Holder: Matthews Holdings Southwest, Inc.
Signature of Authorized Signatory of Holder: /s/ Adam Miller
Name of Authorized Signatory: Adam Miller, CFO
[Signature Page to Heart Test Laboratories, Inc. Warrant Amendment Agreement]
EXHIBIT A
EXISTING WARRANTS
Transaction/Warrant Date | Shares | Strike Price | ||||||
September 7, 2023 | 500,000 | $ | 1.00 | |||||
September 7, 2023 | 250,000 | $ | 1.25 | |||||
September 7, 2023 | 250,000 | $ | 1.50 |